β¨ Health Notices
11 APRIL
NEW ZEALAND GAZETTE
1017
Health
Burial and Cremation Act 1964
Appointment of Masterton District Council to Have the Control and Management of Hastwell Cemetery
Pursuant to section 23 (3) of the Burial and Cremation Act 1964, the Governor-General has appointed the Masterton District Council to have the control and management of the Hastwell Cemetery.
Dated at Wellington this 8th day of April 2002.
RUTH DYSON, Associate Minister of Health.
go2449
Medicines Act 1981
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Flexetor
Active Ingredient: Fluoxetine hydrochloride 22.36mg equivalent to 20 mg fluoxetine
Dosage Form: Capsule
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Rolab Limited, Spartan, Kempton Park, South Africa
Rottendorf Pharma Pty Limited, Enningerloh, Germany
Product: Fludara oral
Active Ingredient: Fludarabine phosphate 10mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Schering (NZ) Limited
Manufacturer: Schering AG, Wedding, Berlin, Germany
Product: Ismo 20
Active Ingredient: Isosorbide mononitrate 20mg
Dosage Form: (VO3) Tablet
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturer: Roche Diagnostics GmbH, Mannheim, Germany
Dated this 6th day of April 2002.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).
go2450
Renewal of Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Coumadin
Active Ingredient: Warfarin sodium 1mg
Dosage Form: Tablet
New Zealand Sponsor: Boots Healthcare New Zealand Limited
Manufacturer: The Boots Company Plc., Beeston, Nottingham, United Kingdom
This consent is given subject to the following condition:
β Not to be marketed as substitutable for any other warfarin product as if the 2 products were bioequivalent.
Note: This consent is valid for 2 years from 31 October 2001.
Product: Coumadin
Active Ingredient: Warfarin sodium 2mg
Dosage Form: Tablet
New Zealand Sponsor: Boots Healthcare New Zealand Limited
Manufacturer: The Boots Company Plc., Beeston, Nottingham, United Kingdom
This consent is given subject to the following condition:
β Not to be marketed as substitutable for any other warfarin product as if the 2 products were bioequivalent.
Note: This consent is valid for 2 years from 31 October 2001.
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2002, No 34
Gazette.govt.nz —
NZ Gazette 2002, No 34
β¨ LLM interpretation of page content
π₯ Appointment of Masterton District Council to Manage Hastwell Cemetery
π₯ Health & Social Welfare8 April 2002
Cemetery Management, Masterton District Council, Hastwell Cemetery
- RUTH DYSON, Associate Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare6 April 2002
Medicine Distribution, New Medicines, Flexetor, Fludara oral, Ismo 20
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Renewal of Provisional Consent for Coumadin
π₯ Health & Social Welfare6 April 2002
Medicine Distribution, Provisional Consent, Coumadin, Warfarin sodium
- G. R. BOYD, Chief Advisor, Safety and Regulation